- Home
- VKTX vs CVCO Comparison
VKTX vs CVCO Comparison
Compare VKTX & CVCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VKTX
- CVCO
- Stock Information
- Founded
- VKTX 2012
- CVCO 1965
- Country
- VKTX United States
- CVCO United States
- Employees
- VKTX N/A
- CVCO N/A
- Industry
- VKTX Biotechnology: Pharmaceutical Preparations
- CVCO Homebuilding
- Sector
- VKTX Health Care
- CVCO Consumer Discretionary
- Exchange
- VKTX Nasdaq
- CVCO Nasdaq
- Market Cap
- VKTX 3.5B
- CVCO 3.6B
- IPO Year
- VKTX 2015
- CVCO N/A
- Fundamental
- Price
- VKTX $26.98
- CVCO $545.84
- Analyst Decision
- VKTX Strong Buy
- CVCO Buy
- Analyst Count
- VKTX 13
- CVCO 2
- Target Price
- VKTX $86.92
- CVCO $522.50
- AVG Volume (30 Days)
- VKTX 9.7M
- CVCO 148.7K
- Earning Date
- VKTX 10-22-2025
- CVCO 10-30-2025
- Dividend Yield
- VKTX N/A
- CVCO N/A
- EPS Growth
- VKTX N/A
- CVCO 34.06
- EPS
- VKTX N/A
- CVCO 23.02
- Revenue
- VKTX N/A
- CVCO $2,094,716,000.00
- Revenue This Year
- VKTX N/A
- CVCO $9.80
- Revenue Next Year
- VKTX N/A
- CVCO $6.01
- P/E Ratio
- VKTX N/A
- CVCO $23.90
- Revenue Growth
- VKTX N/A
- CVCO 16.60
- 52 Week Low
- VKTX $18.92
- CVCO $390.46
- 52 Week High
- VKTX $81.73
- CVCO $567.47
- Technical
- Relative Strength Index (RSI)
- VKTX 41.03
- CVCO 73.22
- Support Level
- VKTX $26.13
- CVCO $522.32
- Resistance Level
- VKTX $28.26
- CVCO $536.57
- Average True Range (ATR)
- VKTX 1.63
- CVCO 16.26
- MACD
- VKTX -0.39
- CVCO 3.02
- Stochastic Oscillator
- VKTX 19.82
- CVCO 74.74
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
About CVCO Cavco Industries Inc. When Issued
Cavco Industries Inc designs and produces factory-built homes under the Cavco Homes, Fleetwood Homes, and Palm Harbor Homes brands. It also produces modular homes, park model homes, and vacation cabins, as well as commercial structures, among others. The company operates principally in two segments: Factory-built housing, which includes wholesale and retail systems-built housing operations, and the Financial services segment, which includes manufactured housing consumer finance and insurance. Cavco receives a majority of its revenue from the Factory-built housing segment.